Epidemiology and Prevention of Prostate Cancer.
9 auth.
G. Gandaglia,
R. Leni,
F. Bray,
N. Fleshner,
S. Freedland,
A. Kibel,
...
P. Stattin,
H. Van Poppel,
C. la Vecchia
|
8 |
2021 |
8
2021
|
Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial.
F. Giganti,
C. Allen,
M. Emberton,
C. Moore,
V. Kasivisvanathan
|
7 |
2020 |
7
2020
|
Epidemiology, Screening, and Prevention of Bladder Cancer.
10 auth.
N. Lobo,
L. Afferi,
M. Moschini,
H. Mostafid,
S. Porten,
S. Psutka,
...
Shilpa Gupta,
Angela B. Smith,
S. Williams,
Y. Lotan
|
7 |
2022 |
7
2022
|
A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer.
11 auth.
P. D. De Visschere,
Chloë Standaert,
J. Fütterer,
G. Villeirs,
V. Panebianco,
J. Walz,
...
T. Maurer,
B. Hadaschik,
F. Lecouvet,
G. Giannarini,
S. Fanti
|
7 |
2019 |
7
2019
|
Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand Therapy.
11 auth.
S. Thang,
J. Violet,
S. Sandhu,
A. Iravani,
T. Akhurst,
G. Kong,
...
A. R. Ravi Kumar,
D. Murphy,
S. Williams,
R. Hicks,
M. Hofman
|
7 |
2019 |
7
2019
|
Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial.
11 auth.
J. Witjes,
J. Morote,
E. Cornel,
G. Gakis,
F. J. P. van Valenberg,
F. Lozano,
...
I. Sternberg,
E. Willemsen,
Miriam L. Hegemann,
Y. Paitan,
I. Leibovitch
|
7 |
2018 |
7
2018
|
Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies.
Nicholas G Zaorsky,
E. Lehrer,
G. Kothari,
A. Louie,
S. Siva
|
6 |
2019 |
6
2019
|
First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis.
13 auth.
F. Quhal,
K. Mori,
A. Bruchbacher,
I. Resch,
H. Mostafaei,
B. Pradère,
V. Schuettfort,
E. Laukhtina,
S. Egawa,
H. Fajkovic,
...
M. Remzi,
S. Shariat,
M. Schmidinger
|
6 |
2021 |
6
2021
|
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.
15 auth.
E. Mazzone,
A. Stabile,
F. Pellegrino,
G. Basile,
D. Cignoli,
G. Cirulli,
G. Sorce,
F. Barletta,
S. Scuderi,
C. Bravi,
...
V. Cucchiara*,
N. Fossati,
G. Gandaglia,
F. Montorsi,
A. Briganti
|
6 |
2020 |
6
2020
|
Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
12 auth.
S. Woo,
V. Panebianco,
Y. Narumi,
F. del Giudice,
V. Muglia,
Mitsuru Takeuchi,
...
Soleen Ghafoor,
B. Bochner,
A. Goh,
H. Hricak,
J. Catto,
H. Vargas
|
6 |
2020 |
6
2020
|
Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial.
8 auth.
K. Touijer,
D. Sjoberg,
N. Benfante,
V. Laudone,
B. Ehdaie,
J. Eastham,
...
P. Scardino,
A. Vickers
|
6 |
2021 |
6
2021
|
Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States.
7 auth.
H. Patel,
Mohit Gupta,
G. Joice,
A. Srivastava,
R. Alam,
M. Allaf,
...
P. Pierorazio
|
6 |
2019 |
6
2019
|
What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Gu
9 auth.
E. Veskimäe,
E. L. Espinós,
H. M. Bruins,
Yuhong Yuan,
R. Sylvester,
A. Kamat,
...
S. Shariat,
J. Witjes,
E. Compérat
|
6 |
2019 |
6
2019
|
